Sleeping and calming medicines
Insomnia: CBT-I first, exceptional short-term use of sleeping medicines, dependence risks and supported tapering under Belgium's 2026 guidance.
Loading project statuses…
Insomnia: CBT-I first, exceptional short-term use of sleeping medicines, dependence risks and supported tapering under Belgium's 2026 guidance.